• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双特异性磷酸酶作为抗肿瘤药物的靶点。

Dual-specificity phosphatases as targets for antineoplastic agents.

作者信息

Lyon Michael A, Ducruet Alexander P, Wipf Peter, Lazo John S

机构信息

Department of Chemistry, Chevron Science Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA.

出版信息

Nat Rev Drug Discov. 2002 Dec;1(12):961-76. doi: 10.1038/nrd963.

DOI:10.1038/nrd963
PMID:12461518
Abstract

Dual-specificity protein phosphatases are a subclass of protein tyrosine phosphatases that are uniquely able to hydrolyse the phosphate ester bond on both a tyrosine and a threonine or serine residue on the same protein. Dual-specificity phosphatases have a central role in the complex regulation of signalling pathways that are involved in cell stress responses, proliferation and death. Although this enzyme family is increasingly the target of drug discovery efforts in pharmaceutical companies, a summary of the salient developments in the biology and medicinal chemistry of dual-specificity phosphatases has been lacking. We hope that this comprehensive overview will stimulate further progress in the development of small-molecule inhibitors that could form the basis for a new class of target-directed therapeutic agents.

摘要

双特异性蛋白磷酸酶是蛋白酪氨酸磷酸酶的一个亚类,其独特之处在于能够水解同一蛋白质上酪氨酸以及苏氨酸或丝氨酸残基上的磷酸酯键。双特异性磷酸酶在参与细胞应激反应、增殖和死亡的信号通路的复杂调控中发挥着核心作用。尽管该酶家族日益成为制药公司药物研发工作的靶点,但一直缺乏对双特异性磷酸酶生物学和药物化学显著进展的总结。我们希望这一全面综述将推动小分子抑制剂研发取得进一步进展,这些抑制剂可能成为一类新型靶向治疗药物的基础。

相似文献

1
Dual-specificity phosphatases as targets for antineoplastic agents.双特异性磷酸酶作为抗肿瘤药物的靶点。
Nat Rev Drug Discov. 2002 Dec;1(12):961-76. doi: 10.1038/nrd963.
2
Small molecule inhibitors of dual specificity protein phosphatases.双特异性蛋白磷酸酶的小分子抑制剂
Oncogene. 2000 Dec 27;19(56):6607-12. doi: 10.1038/sj.onc.1204084.
3
Inhibitors of protein tyrosine phosphatases: next-generation drugs?蛋白酪氨酸磷酸酶抑制剂:新一代药物?
Angew Chem Int Ed Engl. 2005 Jun 20;44(25):3814-39. doi: 10.1002/anie.200461517.
4
PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.蛋白酪氨酸磷酸酶1B作为药物靶点:蛋白酪氨酸磷酸酶1B抑制剂发现的最新进展
Drug Discov Today. 2007 May;12(9-10):373-81. doi: 10.1016/j.drudis.2007.03.011. Epub 2007 Apr 6.
5
A one-step method to identify MAP kinase residues involved in inactivation by tyrosine- and dual-specificity protein phosphatases.一种鉴定参与酪氨酸和双特异性蛋白磷酸酶失活的丝裂原活化蛋白激酶残基的一步法。
Anal Biochem. 2009 Nov 1;394(1):81-6. doi: 10.1016/j.ab.2009.07.006. Epub 2009 Jul 5.
6
Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development.蛋白酪氨酸磷酸酶作为药物靶点:抑制剂开发的策略和挑战。
Future Med Chem. 2010 Oct;2(10):1563-76. doi: 10.4155/fmc.10.241.
7
Squaric acids: a new motif for designing inhibitors of protein tyrosine phosphatases.方酸:一种设计蛋白酪氨酸磷酸酶抑制剂的新基序。
Org Lett. 2004 Jan 8;6(1):83-6. doi: 10.1021/ol036121w.
8
Using small molecules to target protein phosphatases.利用小分子靶向蛋白磷酸酶。
Bioorg Med Chem. 2011 Apr 1;19(7):2145-55. doi: 10.1016/j.bmc.2011.02.047. Epub 2011 Mar 2.
9
Protein tyrosine phosphatases in cancer: friends and foes!癌症中的蛋白酪氨酸磷酸酶:朋友还是敌人!
Prog Mol Biol Transl Sci. 2012;106:253-306. doi: 10.1016/B978-0-12-396456-4.00009-2.
10
The therapeutic potential of phosphatase inhibitors.磷酸酶抑制剂的治疗潜力。
Curr Opin Chem Biol. 2009 Jun;13(3):272-83. doi: 10.1016/j.cbpa.2009.03.021. Epub 2009 May 4.

引用本文的文献

1
Induction of the hepatic aryl hydrocarbon receptor by alcohol dysregulates autophagy and phospholipid metabolism via PPP2R2D.酒精诱导肝芳香烃受体通过 PPP2R2D 失调自噬和磷脂代谢。
Nat Commun. 2022 Oct 14;13(1):6080. doi: 10.1038/s41467-022-33749-0.
2
Exposure of the cytoplasm to low-dose X-rays modifies ataxia telangiectasia mutated-mediated DNA damage responses.低剂量 X 射线照射细胞质会改变共济失调毛细血管扩张突变基因介导的 DNA 损伤反应。
Sci Rep. 2021 Jul 5;11(1):13113. doi: 10.1038/s41598-021-92213-z.
3
Comparative genomics reveals high biological diversity and specific adaptations in the industrially and medically important fungal genus Aspergillus.
比较基因组学揭示了在工业和医学上具有重要意义的真菌曲霉属中存在高度的生物多样性和特定适应性。
Genome Biol. 2017 Feb 14;18(1):28. doi: 10.1186/s13059-017-1151-0.
4
Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options.蛋白磷酸酶2A(PP2A)在癌症中的失调:复杂性与治疗选择
Tumour Biol. 2016 Sep;37(9):11691-11700. doi: 10.1007/s13277-016-5145-4. Epub 2016 Jul 21.
5
Inhibition of CDC25B phosphatase through disruption of protein-protein interaction.通过破坏蛋白质-蛋白质相互作用来抑制细胞周期蛋白依赖性激酶25B磷酸酶
ACS Chem Biol. 2015 Feb 20;10(2):390-4. doi: 10.1021/cb500883h. Epub 2014 Dec 1.
6
Protein tyrosine phosphatases as potential therapeutic targets.蛋白酪氨酸磷酸酶作为潜在的治疗靶点。
Acta Pharmacol Sin. 2014 Oct;35(10):1227-46. doi: 10.1038/aps.2014.80. Epub 2014 Sep 15.
7
Targeting cell division cycle 25 homolog B to regulate influenza virus replication.针对细胞分裂周期 25 同源物 B 调节流感病毒复制。
J Virol. 2013 Dec;87(24):13775-84. doi: 10.1128/JVI.01509-13. Epub 2013 Oct 9.
8
Specific targeting of caspase-9/PP2A interaction as potential new anti-cancer therapy.靶向 Caspase-9/PP2A 相互作用作为潜在的新型抗癌疗法。
PLoS One. 2013 Apr 23;8(4):e60816. doi: 10.1371/journal.pone.0060816. Print 2013.
9
Dual-Specificity Phosphatase CDC25A/B Inhibitor Identified from a Focused Library with Nonelectrophilic Core Structure.从具有非亲电核心结构的聚焦文库中鉴定出的双特异性磷酸酶CDC25A/B抑制剂。
ACS Med Chem Lett. 2012 Apr 12;3(4):294-298. doi: 10.1021/ml2002778. Epub 2012 Feb 15.
10
Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.高磷酸酶再生肝脏-3 表达对接受根治性胃切除术的胃癌患者的预后意义。
Dig Dis Sci. 2012 Jun;57(6):1568-75. doi: 10.1007/s10620-012-2076-9. Epub 2012 Feb 14.